Indian Biotech Industry (2005)

Publication Date	October 2005
Publisher	RNCOS
Product Type	Report
Pages	75
ISBN Number	not applicable
Product Code	RCS00068

Price

£1,010.00
approximately: $1,500 | €1,189

PDF

PRINT £1,075 ($1,596 | €1,265)

CD-ROM £1,075 ($1,596 | €1,265)

Order above formats by FAX

Summary

India being on the 'threshold of biotech revolution' has 280 biotech and 180 bio suppliers contributing to the total biotech market worth US $100 billion. The country has a global market worth $91 billion and there is scope for cheap R&D through bio-partnering and co-developing technologies mainly with Chinese and American companies. Already the world pharma companies are seeking India to set their research and development centers here. Moreover, to facilitate foreign investment, capital and government policies are being revised.

It has been found that Indian biotech firms are making a strong position, developing business models and improving product commercialization capabilities. With this, India could make a good $5 billion by 2010.

A new market research report, "Indian Biotech Industry (2005)" provides insights into the Indian biotech industry including product estimates, market segmentation, and regulatory mechanisms, pricing policies, patents and opportunities in international venture ship. The report says how in 2004-05, 20 privately helped drug discovery groups have started to operate in India with their business primarily to create innovations and IPR. The biotech industry is likely to draw huge FDI to the Union Government.

The market research report also details the success of the biotech firms in terms of their business profiles, export outlets, financial performances and future plans. It also has the contact details of the major industry associations.

Report Highlights

Assessment of what is happening in China across the value chain, the organizational structure and, the interaction between Indo-China biotech businesses and research.
Changes in patent policies and Intellectual Property Rights - A strategic analysis
Sales and demand analysis for biotech products in agri-business and clinical studies, 2005-2010.
An estimate of the recent and future investment programs in Indian biotechnology sector and its growth statistics.
SWOT analysis of Indian biotechnology sector.
New drafts and policies formulated by the National Biotechnology Development Authorities and how it facilitates in private-public partnerships across biotech firms.
Key profiles and marketing strategies.

Report Features

The market research report "Indian Biotech Industry (2005)" gives a detail analysis of the Indian biotech market scenario, the technological developments and researches. These have been divided into a number of relevant chapters. Chapter 1 giving an introduction is followed by chapter 2 which talks about the changing legal framework of the biotech sector in India mentioning, fiscal incentives, changes in patents acts, plant varieties and Farmers' Rights Protection Act, 2001 and other regulations for the biotech sector. Chapter 3 gives the state driven initiatives and policies, region wise.

Chapter 4 analyzes the Indian biotechnology market for 2005 in terms of size, demand, industry segments, exports, number of companies & associations, employment opportunities, investments and status of biotech parks. Chapter 5 gives the SWOT analysis whereas the chapter 6 discuss about the Indian Biotechnology Industries and outsourcing opportunities. Chapter 7, 8 and 9 talk about R&D strengths, India's New Draft National Biotechnology Development strategy and the key industry trends and opportunities in biotech industry. Chapter 10 and 11 covers strategies for the industry's future and financial strategy for emerging bio-companies. Finally, chapter 12 gives the company profiles of key players.

Content

1. Biotechnology in India - An Introduction
2. Biotech Sector in India: Changing Legal Framework
- 2.1 Fiscal Incentives provided to the Biotech Sector
- 2.2 Important Changes to the Patents Act Proposed in the Third Amendment Bill
- 2.3 Plant Varieties and Farmers' Rights Protection Act, 2001
- 2.4 Other Regulations Impacting the Biotech Sector
  - 2.4.1 Licensing
  - 2.4.2 Clinical Trials
  - 2.4.3 Seeds Act and Policy
  - 2.4.4 Environmental Clearances
  - 2.4.5 Biodiversity
- 2.5 Status on Enforcement
3. Bio-Clusters: State Driven Initiatives and Policies
- 3.1 Southern Region
- 3.2 Western Region
- 3.3 Northern Region
4. Indian Biotechnology Market Analysis, 2005
- 4.1 Total Market Size, (%) 2005
- 4.2 Growth Forecasts for the Indian Biotechnology Industry ($ Million), 2007-2010
- 4.3 Market Size by Industry Segments (%), 2005
  - 4.3.1 Biopharmaceuticals
  - 4.3.2 Bioinformatics
  - 4.3.3 Industrial Biotech
  - 4.3.4 Agri Biotech
  - 4.3.5 Bioservices (Contract Research)
  - 4.3.6 Employment in Indian Biotech Industry, (%)
- 4.4 Biotech Exports, by Segment-wise (%), 2005
  - 4.4.1 Biotech Suppliers
- 4.5 Number of Companies and Associations (in numbers), 2005
- 4.6 Employment Opportunities in India
- 4.7 Investments in Indian Biotechnology Sector, 2005
- 4.8 Status of Biotech Parks in India
5. SWOT Analysis of Indian Biotechnology Sector
6. India Biotechnology Industry and Outsourcing Opportunities
7. India's Biotechnology Research and Development Strengths
8. India's New Draft National Biotechnology Development Strategy - Geared Towards Encouraging Public-Private Partnership
9. Key Industry Trends and Opportunities in Indian Biotech Industry
10. Strategies for the Indian Biotech Industry Future
- 10.1 Generate National Level Resource Strength in Bioinformatics
- 10.2 Promote R&D Strengths
- 10.3 Promote Entrepreneurial Development
- 10.4 Globalization of the National Bioinformatics Initiatives
- 10.5 Encourage Human Resource Development, Education, & Awareness
- 10.6 Restructuring of the BTIS Organization for Optimized Performance
11. Financial Strategy for Emerging Bio-Companies
12. Company Profiles of Key Players
- 12.1 Biocon
- 12.2 Serum Institute of India
- 12.3 Panacea Biotech
- 12.4 Nicholas Piramal
- 12.5 Wockhardt Limited
- 12.6 GlaxoSmithKline
- 12.7 Bharat Serums
- 12.8 Krebs Biochemical's & Industries Limited
- 12.9 Indian Immunologicals
- 12.10 Zydus Cadila
- 12.11 Shantha Biotechnics
- 12.12 Biological E
- 12.13 Chiron Behring Vaccines
- 12.14 Eli Lilly and Company
- 12.15 Novo Nordisk
- 12.16 Mahyco Monsanto
- 12.17 Bharat Biotech
- 12.18 Abbott
- 12.19 Ranbaxy
- 12.20 Novozymes
List of Figures:
- Figure 1-1: Budgetary Allocation of Major Funding Agencies in India (1990-91 & 2000-01)
- Figure 4-1: Indian Biotechnology Industry Revenue Growth ($ Million), 2003 & 2004
- Figure 4-2: Market Size by Industry Segments (%), 2003 & 2004
- Figure 4-3: Percentage Growth in Each Segment
- Figure 4-4: Biotech Industry's Revenue ($ Billion), 2004 & 2010
- Figure 4-5: Percentage of Revenues from BioPharma (2004 & 2005)
- Figure 4-6: Percentage Growth in Market Share
- Figure 4-7: Percentage Market Share by Different Companies in India (2004-2005)
- Figure 4-8: Revenues for Top 5 BioService Players (2004 & 2005)
- Figure 4-9: BioService Market Share in Percentage (2004-2005)
- Figure 4-10: Indian Biotech Industry - Total Manpower (%), 2005
- Figure 4-11: Exports Vs Domestic Business - Percentage Market Share by Each Segment (2004-2005)
- Figure 4-12: Domestic Market - Segment Market Share (%)
- Figure 4-13: Export Market - Segment Market Share (%)
- Figure 4-14: Biotech Suppliers - Percentage Growth (2004-2005)
- Figure 4-15: Top 9 Indian Manufacturers - Turnover (in % growth), 2004-2005
- Figure 4-16: Investments in Indian Biotech Industry (%), 2000-01 to 2004-05
List of Tables:
- Table 4-1: Permitted BT Cotton Seeds
- Table 4-2: Top 20 Biotech Companies in World (2004 & 2005)
- Table 4-3: Top 20 Biotech Companies in India (2004 & 2005)